Amendment_0001_BioRad_Lab_Quality_Control_Reagents_Taos_Picuris_Service_Unit

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

ALBUQUERQUE AREA INDIAN HEALTH SVC

Contract Value

Not provided

Codes & Classification
Solicitation Number

75H70726Q00102

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6550

Additional Details
Set Aside

ISBEE

Place of Performance

Taos, New Mexico, UNITED STATES

SourceSAM
The Albuquerque Area Indian Health Service (IHS), operating under the Department of Health and Human Services, has issued a combined synopsis/solicitation (RFQ No. 75H70726Q00102) for the procurement of BioRad Laboratories Quality Control Reagents. This requirement is specifically for the Laboratory Department at the Taos-Picuris Indian Health Center, located at 1090 Goat Springs Road, Taos, New Mexico 87571. The purpose of this procurement is to acquire commercial quality control reagents manufactured by BioRad Laboratories, which are essential for ensuring the accuracy and reliability of laboratory diagnostic testing at the health center. The scope of work encompasses the supply and delivery of these reagents, as detailed in the attached RFQ and fillable pricing table, which outline the specific contract line-items (CLINs) and requirements. The intended outcome is to support the laboratory’s ongoing operations and maintain high standards of patient care through consistent and reliable diagnostic quality control. This solicitation is issued in accordance with FAR Part 12 for commercial products or services and constitutes the only solicitation; no separate written solicitation will be provided. The acquisition is set aside exclusively for Indian Small Business Economic Enterprises (ISBEE) under the Buy Indian Act (25 U.S.C. 47), as implemented by HHSAR Subpart 326.6. The procurement features a cascading set-aside structure: if insufficient competition or reasonably priced offers are received from ISBEE firms, consideration will extend to Service-Disabled Veteran-Owned Small Businesses (SDVOSB), HUBZone Small Businesses, Small Disadvantaged Businesses (SDB), and ultimately to all other small business concerns. Key requirements include adherence to the NAICS Code 325413 (In-Vitro Diagnostic Substance Manufacturing), with applicable Product Service Code 6550. Offerors must review the attached RFQ for a comprehensive description of requirements, applicable solicitation provisions, and contract clauses. The procurement is classified as a commercial item acquisition, and all relevant federal acquisition regulations and clauses apply. Interested contractors must submit their quotes via email to the Contract Administrator, Tamela Richards, at [email protected], no later than 12:30 pm MDT on Monday, September 7, 2026. Questions regarding the solicitation should be submitted by 4:30 pm MDT on Wednesday, September 2, 2026, also via email, with “RFQ No. 75H70726Q00102” in the subject line. The contracting entity is the Albuquerque Area Indian Health Service, a federal office under the Indian Health Service agency. Contractors evaluating this opportunity should note the ISBEE set-aside requirement and the cascading set-aside structure, ensuring eligibility and compliance with the Buy Indian Act. The place of performance is Taos, New Mexico, and the contract will support the laboratory operations at the Taos-Picuris Indian Health Center. All provisions and clauses referenced in the solicitation are accessible at www.acquisition.gov. For further information, contractors may contact Tamela Richards at (505) 256-6762 or via email. This procurement represents a stable, ongoing requirement for laboratory quality control reagents, supporting the health center’s mission to deliver high-quality healthcare services to the local community. Contractors with relevant manufacturing capabilities and experience in supplying in-vitro diagnostic substances are encouraged to review the RFQ attachments and consider submitting a responsive quote.
Documents7